2017-2018 RSV Season
Criteria for Reimbursement of Palivizumab (Synagis ®) for 2017-2018 RSV Season (Medicaid Provider) 10/01/17
Palivizumab Clinical Pre-Authorization Form 10/01/17
Palivizumab Request for Reconsideration 10/01/17
To view previous years announcements, click here